Matches in Wikidata for { <http://www.wikidata.org/entity/Q96307982> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q96307982 description "2020 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q96307982 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96307982 description "scientific article published on 10 June 2020" @default.
- Q96307982 description "wetenschappelijk artikel" @default.
- Q96307982 description "наукова стаття, опублікована 10 червня 2020" @default.
- Q96307982 name "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 name "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 type Item @default.
- Q96307982 label "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 label "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 prefLabel "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 prefLabel "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 P1433 Q96307982-FE40DBE7-C6DF-437D-BA1E-814CF9101E98 @default.
- Q96307982 P1476 Q96307982-FC118E1D-A822-4B95-9C59-BD7253869D37 @default.
- Q96307982 P2093 Q96307982-17FB0FE9-9BE3-4715-A210-1152E9908280 @default.
- Q96307982 P2093 Q96307982-18F079E0-3775-43FF-8128-37126156CECC @default.
- Q96307982 P2093 Q96307982-48B8D310-42E7-4570-9757-A8AFE14E38A8 @default.
- Q96307982 P2093 Q96307982-49339C5A-5255-4555-A354-57A70C770C75 @default.
- Q96307982 P2093 Q96307982-5DE1FBA4-8635-46C6-AE99-C4957C6E54B1 @default.
- Q96307982 P2093 Q96307982-6425AF17-F38D-4D62-8E76-8125BB549CA6 @default.
- Q96307982 P2093 Q96307982-6DA801CC-DA75-4DE4-B86A-D4FBC370A08E @default.
- Q96307982 P2093 Q96307982-8B59C8D1-F329-46A6-8AEE-B7D96A1150A2 @default.
- Q96307982 P2093 Q96307982-D99569E4-1F7F-4E58-B3C5-502163597993 @default.
- Q96307982 P2093 Q96307982-EEA6DF0D-686B-47F6-A910-1640919CC169 @default.
- Q96307982 P2093 Q96307982-FD6F714F-DBE0-4A99-86E1-E920C5AE4173 @default.
- Q96307982 P31 Q96307982-0D064E12-522F-444F-B98A-67C3C4781AE7 @default.
- Q96307982 P356 Q96307982-7641F337-EDA7-43E1-9186-083F818DD892 @default.
- Q96307982 P577 Q96307982-507EF0AA-D983-45F9-9175-25E4432A217A @default.
- Q96307982 P698 Q96307982-400D7AE9-F674-4983-B689-547066DBDA14 @default.
- Q96307982 P921 Q96307982-5F65EFA9-80C4-4FA9-A545-13F1ABF9DC78 @default.
- Q96307982 P921 Q96307982-A06940D6-55EB-441E-ACC7-9C180584923C @default.
- Q96307982 P932 Q96307982-197623EA-2185-4963-A554-AA38F805E283 @default.
- Q96307982 P356 S12325-020-01395-X @default.
- Q96307982 P698 32524500 @default.
- Q96307982 P1433 Q4686392 @default.
- Q96307982 P1476 "Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis" @default.
- Q96307982 P2093 "Anthony Glennane" @default.
- Q96307982 P2093 "Chang-Ki Min" @default.
- Q96307982 P2093 "Cheng-Shyong Chang" @default.
- Q96307982 P2093 "Kazuyuki Shimizu" @default.
- Q96307982 P2093 "Raymond Siu-Ming Wong" @default.
- Q96307982 P2093 "Seasea Gao" @default.
- Q96307982 P2093 "Shang-Yi Huang" @default.
- Q96307982 P2093 "Steve W Gordon" @default.
- Q96307982 P2093 "Sung-Soo Yoon" @default.
- Q96307982 P2093 "Wee Joo Chng" @default.
- Q96307982 P2093 "Yang Wang" @default.
- Q96307982 P31 Q13442814 @default.
- Q96307982 P356 "10.1007/S12325-020-01395-X" @default.
- Q96307982 P577 "2020-06-10T00:00:00Z" @default.
- Q96307982 P698 "32524500" @default.
- Q96307982 P921 Q218507 @default.
- Q96307982 P921 Q4941552 @default.
- Q96307982 P932 "7467415" @default.